Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...
Merck's Keytruda and Eisai's Lenvima combo with chemo failed survival endpoint in gastroesophageal cancer study, but ...
President Donald Trump's communications pause for HHS, FDA and other health-related agencies could push some drug approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback